Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.44 |
| ▸ | RECQL | P46063 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | CASP1 | P29466 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.43 |
| ▸ | CASP7 | P55210 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | CASP6 | P55212 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | ELAVL1 | Q15717 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11337312 | 0.86 | ALDH1A1 (0.50) | ALDH1A1HSD17B10RECQLTSHRCASP1 | |
| SCHEMBL28138578 | 0.85 | ALDH1A1 (0.61) | ALDH1A1HSD17B10RECQLCYP3A4TSHR | |
| SCHEMBL4003250 | 0.82 | CA1 (0.47) | ALDH1A1HSD17B10RECQLCYP3A4TSHR | |
| SCHEMBL10394272 | 0.82 | ALDH1A1 (0.54) | ALDH1A1HSD17B10RECQLCYP3A4TSHR | |
| SCHEMBL23566465 | 0.80 | CA1 (0.46) | ALDH1A1HSD17B10RECQLCYP3A4TSHR | |
| SCHEMBL9680119 | 0.80 | TDP1 (0.47) | ALDH1A1HSD17B10RECQLCYP3A4TSHR | |
| SCHEMBL11692848 | 0.80 | ALDH1A1 (0.47) | ALDH1A1HSD17B10RECQLCYP3A4TSHR | |
| SCHEMBL1365040 | 0.80 | ALDH1A1 (0.46) | ALDH1A1HSD17B10RECQLTSHRCASP1 | |
| SCHEMBL13277835 | 0.78 | CA1 (0.44) | ALDH1A1HSD17B10RECQLCYP3A4TSHR | |
| Hydrochloric Acid SCHEMBL28326253 | 0.78 | CASR (0.41) | ALDH1A1RECQLTSHRTHRBHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE49569-E1 | Alkylamine derivative | EA PHARMA CO., LTD. (JP) | 2023-07-04 | — | — | US | disclosed |
| EP-2546231-B1 | ALKYLAMINE DERIVATIVE | EA PHARMA CO LTD (JP) | 2018-11-07 | — | — | EP | disclosed |
| CN-103951615-B | Alkylamine derivative | EA制药株式会社 | 2017-04-12 | — | — | CN | disclosed |
| US-9561216-B2 | Alkylamine derivative | EA PHARMA CO., LTD. (JP) | 2017-02-07 | — | — | US | disclosed |
| US-20160101091-A1 | ALKYLAMINE DERIVATIVE | AJINOMOTO CO., INC. (JP) | 2016-04-14 | — | — | US | disclosed |
| CN-103980309-B | Casr agonist | AJINOMOTO K. K. (JP) | 2016-04-06 | — | — | CN | disclosed |
| EP-2345636-B1 | CASR AGONIST | AJINOMOTO KK (JP) | 2016-03-30 | — | — | EP | disclosed |
| US-9253997-B2 | Alkylamine derivative | AJINOMOTO CO., INC. (JP) | 2016-02-09 | — | — | US | disclosed |
| US-9174932-B2 | CaSR agonists | AJINOMOTO CO., INC. (JP) | 2015-11-03 | — | — | US | disclosed |
| US-9150505-B2 | Prophylactic or therapeutic agent for diabetes or obesity | AJINOMOTO CO., INC. (JP) | 2015-10-06 | — | — | US | disclosed |
| US-4810302-A | STORAGE STABLE MIXTURES | TOYO INK MANUFACTURING CO., LTD. (JP) | 1989-03-07 | — | — | US | disclosed |
| US-4782140-A | Triazinyl reactive dyes containing additional fiber reactive groups bound through the sulfonylalkylaminoalkylamino bridge | CIBA-GIEGY CORPORATION (US) | 1988-11-01 | — | — | US | disclosed |
| EP-0144766-B1 | REACTIVE DYES, THEIR PREPARATION AND THEIR USE | CIBA-GEIGY AG (CH) | 1988-10-05 | — | — | EP | disclosed |
| US-4754023-A | Reactive dyestuffs comprising a triazine moiety and a vinylsulfonyl moiety both being linked by a substituted alkylene bridge member | CIBA-GEIGY CORPORATION (US) | 1988-06-28 | — | — | US | disclosed |
| EP-0159292-B1 | REACTIVE DYES, THEIR PREPARATION AND THEIR USE | CIBA-GEIGY AG (CH) | 1988-01-07 | — | — | EP | disclosed |
| EP-0159292-A2 | Reactive dyes, their preparation and their use | CIBA-GEIGY AG (CH) | 1985-10-23 | — | — | EP | disclosed |
| EP-0144766-A2 | Reactive dyes, their preparation and their use | CIBA-GEIGY AG (CH) | 1985-06-19 | — | — | EP | disclosed |
| EP-0079562-B1 | WATER-SOLUBLE DISAZO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS DYESTUFFS | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-05-29 | — | — | EP | disclosed |
| EP-0079562-A1 | Water-soluble disazo compounds, process for their preparation and their use as dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-05-25 | — | — | EP | disclosed |
| US-4014866-A | FOR SURFACE COATINGS, PRINTING INKS AND RESINS | BASF AKTIENGESELLSCHAFT (DT) | 1977-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160101091-A1 | ALKYLAMINE DERIVATIVE | CASR, TAAR5, TAAR1 | ALDH1A1 2451/4885HSD17B10 2174/4885RECQL 3095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.